Evaluating a new injectable contraceptive for women
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION - OREGON
This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, especially for women who are obese and may be at risk for blood clots, to see if it can be a safer and easier option without the hormones found in many other contraceptives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11310101 on NIH RePORTER |
What this research studies
This research investigates a new long-acting injectable contraceptive called levonorgestrel butanoate, designed specifically for women, particularly those who are obese and at risk for venous thromboembolism (VTE). The study aims to provide an estrogen-free alternative to traditional contraceptive methods, which often require strict adherence and may pose additional health risks. By conducting a clinical trial, the researchers will assess the efficacy and safety of this new formulation, making it easier for women to manage their contraceptive needs without the associated risks of estrogen. The trial will gather data on how well this new contraceptive works and its potential benefits for women in the target demographic.
Who could benefit from this research
Good fit: Ideal candidates for this research are women of childbearing age, especially those who are obese and seeking estrogen-free contraceptive options.
Not a fit: Patients who are not seeking contraception or who do not fall within the childbearing age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer and more convenient contraceptive option for women, particularly those who are obese.
How similar studies have performed: Previous research has shown success with other long-acting contraceptive methods, suggesting potential for this novel approach.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Jensen, Jeffrey — Oregon Health & Science University
- Study coordinator: Jensen, Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.